Related references
Note: Only part of the references are listed.Identification of thymidylate synthase as a potential therapeutic target for lung cancer
K. Takezawa et al.
BRITISH JOURNAL OF CANCER (2010)
Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Hiroaki Ozasa et al.
CANCER SCIENCE (2010)
Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy
Luisella Righi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
TAK-701, a Humanized Monoclonal Antibody to Hepatocyte Growth Factor, Reverses Gefitinib Resistance Induced by Tumor-Derived HGF in Non-Small Cell Lung Cancer with an EGFR Mutation
Wataru Okamoto et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung
Valentina Monica et al.
CLINICAL CANCER RESEARCH (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells
Elisa Giovannetti et al.
MOLECULAR PHARMACOLOGY (2008)
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase
Paolo Ceppi et al.
CANCER (2006)
A phase II trial of pemetrexed in advanced breast cancer: Clinical response and association with molecular target expression
HL Gomez et al.
CLINICAL CANCER RESEARCH (2006)
Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression
J Sigmond et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
